The FDA has updated the Fact Sheet for Health Care Providers for PrEP Pemgarda to include new data against circulating SARS-CoV-2 variants.

In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.

Lung ultrasound (LUS) is as effective as chest radiography (CXR) in diagnosing childhood community-acquired pneumonia, according to systematic review and meta-analysis findings published in Pediatric ...

FDA has approved Tagrisso for the treatment of adult patients with locally advanced, unresectable NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based ...

HealthDay News — Vaping is tied to lower cognitive scores in college students, according to a study presented at the annual meeting of the American Neurological Association, held from Sept. 14 to 17 ...

Age at menarche and duration of breastfeeding were both positively correlated with hand grip strength among older female individuals.

Positive leadership communication can be an effective tool to reduce turnover and burnout among employees in the healthcare ...

Neffy, an intranasal formulation of epinephrine, is now available for emergency treatment of type I allergic reactions.

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September.